Heart involvement in multisystem inflammatory syndrome associated with COVID-19 in children (MIS-C) is a new challenging problem, requiring fast and reliable diagnostics and appropriate treatment. The aim of this study is to describe heart involvement in patients with MIS-C.
In this retrospective, multicenter cohort study, data of 122 patients were included. All patients met WHO and CDC criteria of MIS-C.
Various types of heart involvement in MIS-C patients were observed. Patients with solely coronary artery lesions (CAL,
The above-suggested criteria can be added to routine diagnostic procedures to confirm MI in MIS-C patients.